U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07321106) titled 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer' on Dec. 15, 2025.
Brief Summary: This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or metastatic Microsatellite Stable (MSS)/Microsatellite Instability Low (MSI-L) Colorectal Cancer
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Colorectal Cancer (CRC)
Colorectal (Colon or Rectal) Cancer
CRC
Metastatic Colon Cancer
Col...